Chiral Technologies Worldwide Launches New Microsite for Custom Separation Services
January 20, 2011
WEST CHESTER, Pa. - Chiral Technologies Worldwide (CTW), the world’s leading supplier of chirality tools, has launched a new microsite (http://www.chiralseparationservices.com) dedicated to chiral compound separation science. CTW’s custom separation services focus on rapid and cost-effective production of single-enantiomer compounds. The new microsite provides information about CTW’s capabilities and capacities. CTW laboratories are equipped with [...]
OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
January 20, 2011
Rockville, MD - OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and [...]
January 20, 2011
SCOTTSDALE, AZ - Health Enhancement Products, Inc. (OTCBB: HEPI) has contracted the analytical services arm of scientific instrument maker Bruker Corporation, based in Billerica, MA, to conduct liquid chromatography, nuclear magnetic resonance and mass spectroscopy on the final remaining isolates identified by the HEPI research team over the last year. This latest news caps months [...]
Agilent Technologies Signs Agreement to Acquire Assets of A2 Technologies
January 19, 2011
SANTA CLARA, Calif., and DANBURY, Conn. - Agilent Technologies Inc. (NYSE: A) and A2 Technologies today announced they have signed a definitive agreement for Agilent to acquire specific assets of A2 Technologies. The acquisition includes substantially all of A2 Technologies' intellectual property, technology, employees and its spectroscopy product portfolio. Subject to customary closing conditions, the [...]
Cellectis’ Meganuclease Technology Used to Efficiently Prevent Viral Infection
January 19, 2011
Paris - Cellectis (Alternext: ALCLS), announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary Meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1). The research has just been published online by Molecular Therapy (Mol. [...]
January 19, 2011
SANTA CLARA, CA., USA / Amsterdam, The Netherlands - Agilent Technologies Inc. and Kreatech Diagnostics today announced they are broadening their current business collaboration with an additional license and supply agreement for Kreatech's patented ULS™ (Universal Linkage System) technology and products. The new agreement allows US-based Agilent to incorporate Kreatech's unique ULS™ technology into future [...]
AllCells LLC Strengthens Sales and Marketing Team
January 19, 2011
EMERYVILLE, Calif. - AllCells LLC, a leading global provider of human hematopoietic primary cells and services, today announced that Jack Zhai has joined the company’s executive leadership team as Vice President, Sales & Marketing. Mr. Zhai received his Ph.D. in Cell and Molecular Biology at UW-Madison. In addition, the company recently strengthened its sales force [...]
January 19, 2011
PALO ALTO, Calif. - StemCells, Inc. (Nasdaq:STEM) announced today the launch of STEM24™ and STEM133™, two new antibody reagents that have utility for the isolation and detection of a range of different human cell types. These antibodies are the latest additions to the Company's SC Proven® portfolio of innovative research products. "We plan to continue [...]
January 19, 2011
MENLO PARK, Calif. - SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced that the company will offer FuGENE® HD transfection reagent as an individual product and as part of its novel LightSwitch Transfection Optimization Kit. SwitchGear has also recently launched the innovative LightSwitch Luciferase [...]
GE Partners with Avery Dennison to Commercialize Radio Frequency Sensor Technology
January 19, 2011
NISKAYUNA, N.Y. - GE (NYSE: GE), acting through its Technology Ventures operation, today announced its intent to commercialize GE’s Radio Frequency Sensing technology (RFS) through a commercial license to the RFID division of Avery Dennison (NYSE: AVY). The proprietary RFS technology will enable a wide range of low-cost wireless sensing products in a series of [...]